Astrana Health, Inc. (ASTH)
Astrana Health, Inc. (ASTH)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 13,131 | 6,562 | 1,077 | 16,437 |
| Depreciation and amortization | 15,479 | 16,401 | 15,596 | 13,752 |
| Amortization of debt issuance cost | 1,134 | 1,158 | 1,152 | 1,740 |
| Share-based compensation | 9,895 | 11,382 | 7,700 | 19,519 |
| Non-cash lease expense | 2,005 | 2,299 | 1,789 | 2,559 |
| Deferred tax | 1,907 | 637 | -2,963 | -1,961 |
| Change in fair value of contingent consideration liabilities | 581 | 5,166 | NaN | NaN |
| Other | -2,564 | -7,268 | 1,051 | 3,910 |
| Receivables, net | NaN | 9,424 | NaN | NaN |
| Other receivables | NaN | -2,261 | NaN | NaN |
| Prepaid expenses and other current assets | NaN | -4,718 | NaN | NaN |
| Other assets | NaN | -3,505 | NaN | NaN |
| Accounts payable and accrued expenses | NaN | -6,994 | NaN | NaN |
| Fiduciary accounts payable | NaN | -4,699 | NaN | NaN |
| Medical liabilities | NaN | 8,890 | NaN | NaN |
| Income taxes payable/receivable | NaN | 5,326 | NaN | NaN |
| Operating lease liabilities | NaN | -6,049 | NaN | NaN |
| Other liabilities | NaN | -632 | NaN | NaN |
| Changes in operating assets and liabilities, net of business combinations | -9,637 | NaN | -15,446 | 51,571 |
| Net cash provided by operating activities | 68,056 | -2,886 | 9,956 | 107,527 |
| Payments for business and asset acquisition, net of cash acquired | NaN | 51 | 548,553 | 0 |
| Proceeds from sale of equity method investment | NaN | 0 | 15,100 | NaN |
| Purchases of investments equity method | NaN | 0 | 0 | 0 |
| Purchase of call option issued in conjunction with equity method investment | NaN | 0 | 0 | 0 |
| Issuance of loans receivable | NaN | 0 | 658 | 1,050 |
| Purchases of property and equipment | 4,000 | 3,064 | 2,552 | 4,490 |
| Other | -1,156 | -2,058 | -2,192 | -2,069 |
| Net cash used in investing activities | -2,844 | -1,057 | -534,471 | -3,471 |
| Dividends paid | 104 | 1,556 | 96 | 6,233 |
| Borrowings on long-term debt | NaN | NaN | 707,300 | 412,000 |
| Borrowings on debt | 0 | 1,119,300 | NaN | NaN |
| Repayment of long-term debt | NaN | NaN | 51,966 | 431,357 |
| Repayment of debt | 11,967 | 495,289 | NaN | NaN |
| Deferred financing cost | 0 | 0 | 1,964 | 17,241 |
| Payment of financing obligation | NaN | 0 | NaN | NaN |
| Payment of contingent consideration liabilities | NaN | 0 | 8,284 | NaN |
| Taxes paid from net share settlement of restricted stock | 1,172 | 607 | 509 | 5,053 |
| Repurchase of treasury shares | 2,906 | 15,429 | NaN | NaN |
| Other | 189 | 3,221 | 4,010 | -4,924 |
| Net cash used in financing activities | -15,960 | -26,337 | 648,491 | -52,808 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 49,252 | -30,280 | 123,976 | 51,248 |
| Cash, cash equivalents, and restricted cash, beginning of period | 434,045 | 464,326 | 289,102 | NaN |
| Cash, cash equivalents, and restricted cash, end of period | 483,297 | 434,045 | 464,326 | NaN |